Camberlogo1 (Camberlogo1)
Sildenafil Tablet, Film Coated
Product Images NDC 71205-542
14 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 71205-542). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Camberlogo2 (Camberlogo2)
Sildenafilfigure7 (Sildenafilfigure7)
A bar chart comparing the percentage of patients reporting improvement across four treatment groups: placebo, Sildenafil Citrate tablets 25 mg, 50 mg, and 100 mg. The percentages increase with dose, showing gradual improvement from placebo to the highest dose group.*
71205-542-30 (Sildenafiltab50mg30s)
Sildenafil 50 mg film coated tablets packaging label from Proficient Rx LP. The label indicates 30 tablets per package, each containing sildenafil citrate equivalent to 50 mg sildenafil. Tablets are described as white, round, biconvex, film coated with specific markings. Manufacturer is Hetero Labs Limited, Hyderabad, India. Storage instructions and prescription-only status are included.*
Sildenafilfigure1 (Sildenafilfigure1)
A line graph comparing the effect of 100 mg Sildenafil versus placebo on systolic blood pressure over 24 hours post dose. The x-axis shows time points from pre-dose to 24 hours, and the y-axis represents changes in systolic blood pressure (mmHg). Data points for both Sildenafil and placebo are plotted to illustrate blood pressure variations over time.*
Sildenafilfigure2 (Sildenafilfigure2)
A line graph depicting the change in a variable (measured in ng/mL) over time (in hours postdose) for two groups: placebo and a 50 mg dose of sildenafil. The graph shows curves representing the trends for each group across the time points.*
Sildenafilfigure3 (Sildenafilfigure3)
A line chart comparing percentage change in effect over time (hours postdose) for two treatment groups: Doxazosin with placebo and Doxazosin combined with Sildenafil 50 mg. The x-axis represents time postdose in hours, and the y-axis shows percent change in effect. The chart includes two color-coded lines representing each group across an 8-hour period.*
Sildenafilfigure4 (Sildenafilfigure4)
A line graph showing the effect over time of two treatments, Doxazosin combined with Sildenafil 100 mg and Doxazosin combined with Placebo. The x-axis represents time after dosing in hours (0 to 8 hours), and the y-axis represents the measured variable in mmHg, ranging from 40 to -50. The graph depicts trends for each treatment group over the 8-hour period.*
Sildenafilfigure5 (Sildenafilfigure5)
A line graph depicting plasma concentration (ng/mL) of a drug over 24 hours post-dose. The x-axis shows time in hours, and the y-axis shows plasma concentration, with data represented by a single line labeled 'Commercial Tablet.' Concentration peaks early, then gradually declines over the time period.*
Sildenafilfigure6a (Sildenafilfigure6a)
A bar chart showing the percentage of patients at endpoint according to baseline scores. The x-axis represents baseline scores from 0 to 5, and the y-axis shows the percentage of patients, ranging from 0% to 80%. Multiple bars in different shades represent different score categories or groups as indicated in the legend on the right side.*
Sildenafilfigure6b (Sildenafilfigure6b)
A bar chart illustrating the percentage of patients at endpoint by baseline score categorized from 0 to 5. The bars are segmented with different shading or colors, corresponding to a legend on the right side numbered from 00 to 05. The x-axis represents baseline scores, and the y-axis shows the percentage of patients.*
Sildenafilheterologo1 (Sildenafilheterologo1)
Sildenafilheterologo2 (Sildenafilheterologo2)
Sildenafilstructure (Sildenafilstructure)
Chemical structure of Sildenafil, showing the arrangement of its atoms including a sulfonamide group, a piperazine ring, and a purine-like core structure with various alkyl side chains.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
